These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pulmonary surfactant: anti-atelectasis factor]. Ouellet Y Laval Med; 1970 May; 41(5):627-30. PubMed ID: 4928481 [No Abstract] [Full Text] [Related]
3. Microscopy of the pulmonary alveolar lining layer in rabbits and perinatal infants. DeSa DJ J Pathol; 1969 Sep; 99(1):57-66. PubMed ID: 5359223 [No Abstract] [Full Text] [Related]
4. [Pulmonary surfactan. Current physiological and physiopathological concepts]. Pariente R Presse Med (1893); 1969 Nov; 77(50):1871-2. PubMed ID: 5197179 [No Abstract] [Full Text] [Related]
5. Surfactant of the lung. Heinemann HO Adv Intern Med; 1968; 14():83-105. PubMed ID: 4883747 [No Abstract] [Full Text] [Related]
7. Biochemical development of the lung: clinical aspects of surfactant development, RDS and the intrauterine assessment of lung maturity. Gluck L Clin Obstet Gynecol; 1971 Sep; 14(3):710-21. PubMed ID: 4946202 [No Abstract] [Full Text] [Related]
8. Physiology and pathology of pulmonary surfactants. Scarpelli EM Triangle; 1971; 10(2):47-56. PubMed ID: 5170861 [No Abstract] [Full Text] [Related]
9. [Some findings on pulmonary surfactant by biochemical study]. Fujiwara T Nihon Ishikai Zasshi; 1971 Jul; 66(1):1-15. PubMed ID: 4936298 [No Abstract] [Full Text] [Related]
11. Neonatal hyaline membrane disease: light and electron microscopical studies. Lauweryns JM; Bourgeois N Aspen Emphysema Conf; 1968; 11():3-32. PubMed ID: 5711556 [No Abstract] [Full Text] [Related]
12. [The presence of the "surfactant-system" in the lung as a condition for the repression of upper respiratory tract diseases. 3. Clinical material]. Wildeboer-Venema FN Ned Tijdschr Geneeskd; 1971 Sep; 115(37):1533-8. PubMed ID: 5109628 [No Abstract] [Full Text] [Related]
13. The effect of shock on pulmonary alveolar surfactant. Its role in refractory respiratory insufficiency of the critically ill or severely injured patient. Henry JN J Trauma; 1968 Sep; 8(5):756-73. PubMed ID: 5675600 [No Abstract] [Full Text] [Related]
14. The influence of surface active substances on alveolar mechanics in the respiratory distress syndrome. Rüfer R Respiration; 1968; 25(6):441-57. PubMed ID: 5687215 [No Abstract] [Full Text] [Related]
15. Pulmonary surfactant. Morgan TE N Engl J Med; 1971 May; 284(21):1185-93. PubMed ID: 4929384 [No Abstract] [Full Text] [Related]
16. [Physiopathology and clinical aspects of the alveolar surface active system (pulmonary surfactant)]. Pescetti G; Rigamonti G; Biglino A Minerva Med; 1977 Aug; 68(38):2623-45. PubMed ID: 578568 [TBL] [Abstract][Full Text] [Related]
17. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology. Jobe A Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946 [TBL] [Abstract][Full Text] [Related]